Stem cell transplant and Progressive multifocal leukoencephalopathy

Summary:

Progressive multifocal leukoencephalopathy is found among people with Stem cell transplant, especially for people who are male, 2-9 old.

The study analyzes which people have Progressive multifocal leukoencephalopathy with Stem cell transplant. It is created by eHealthMe based on reports of 87 people who have Stem cell transplant from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Stem cell transplant?

Stem cell transplant is found to be associated with 431 drugs and 383 conditions by eHealthMe. Check the latest studies of Stem cell transplant.

What is Progressive multifocal leukoencephalopathy?

Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells) is found to be associated with 593 drugs and 921 conditions by eHealthMe. Check the latest studies of Progressive multifocal leukoencephalopathy.



On Jul, 12, 2026

87 people who have Stem Cell Transplant and Progressive Multifocal Leukoencephalopathy are studied.

Would you have Progressive multifocal leukoencephalopathy when you have Stem cell transplant?

Gender of people who have Stem Cell Transplant and experienced Progressive Multifocal Leukoencephalopathy *:

  • female: 16.9 %
  • male: 83.1 %

Age of people who have Stem Cell Transplant and experienced Progressive Multifocal Leukoencephalopathy *:

  • 0-1: 0.0 %
  • 2-9: 60.87 %
  • 10-19: 1.45 %
  • 20-29: 1.45 %
  • 30-39: 2.9 %
  • 40-49: 14.49 %
  • 50-59: 7.25 %
  • 60+: 11.59 %

Common co-existing conditions for these people *:

  1. Burkitt Lymphoma (cancer of the lymphatic system): 50 people, 57.47%
  2. Bone Marrow Conditioning Regimen: 48 people, 55.17%
  3. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 6.90%
  4. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 6 people, 6.90%
  5. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 6 people, 6.90%
  6. Hodgkin's Lymphoma (cancer originating from white blood cells): 4 people, 4.60%
  7. Epstein-Barr Virus Infection: 3 people, 3.45%
  8. Cytomegalovirus Infection: 3 people, 3.45%
  9. Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 1 person, 1.15%
  10. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 1.15%

Common drugs taken by these people *:

  1. Zevalin: 48 people, 55.17%
  2. Busulfex: 41 people, 47.13%
  3. Rituxan: 31 people, 35.63%
  4. Ifex: 29 people, 33.33%
  5. Neupogen: 18 people, 20.69%
  6. Cytarabine: 15 people, 17.24%
  7. Fludarabine Phosphate: 15 people, 17.24%
  8. Methotrexate: 14 people, 16.09%
  9. Cisplatin: 13 people, 14.94%
  10. Cyclophosphamide: 13 people, 14.94%

Common symptoms for these people *:

  1. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 57 people, 65.52%
  2. Sepsis (a severe blood infection that can lead to organ failure and death): 51 people, 58.62%
  3. Mucosal Inflammation (infection of mucous membrane): 50 people, 57.47%
  4. Meningitis Tuberculous (a bacterial infection of the membranes covering the brain and spinal cord (meninges)): 50 people, 57.47%
  5. Respiratory Disorder (respiratory disease): 50 people, 57.47%
  6. Herpes Simplex (herpes simplex is a common viral infection): 50 people, 57.47%
  7. Jc Virus Infection: 10 people, 11.49%
  8. Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain): 7 people, 8.05%
  9. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 6 people, 6.90%
  10. Visual Field Defect: 6 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Progressive multifocal leukoencephalopathy?

- Check whether Progressive multifocal leukoencephalopathy is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Progressive multifocal leukoencephalopathy:

All the conditions that are associated with Progressive multifocal leukoencephalopathy:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Progressive multifocal leukoencephalopathy and Stem cell transplant, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: